Carly Rich, PhD

About

• Strategic professional with a PhD in Epidemiology & Biostatistics & nearly 20 years’ experience in designing, conducting, analysing, and reporting of RWE, health economics and patient centred outcomes in various environments including the pharmaceutical industry, consultancy & academia • Currently employed as a global RWE evidence director (HEOR) at SOBI where I provide leadership, expertise and development of all Sobi’s NIS and global value evidence strategies across portfolio. This requires developing payer relevant value evidence strategies, projects, publications and dissemination of outputs to the Global Franchises and Affiliates, as well as engaging and collaborating with key internal and external stakeholders • Experience managing teams of epidemiologists and RWE scientists, providing supervision and strategic input into all aspects of management, leadership, appraisals and projects • Vast experience across a wide range of different therapy areas including rare diseases (including, but not limited to C3G/ IC-MPGN, PNH, ITP, SMA, sHLH, haemophilia), renal diseases, COVID-19, oncology, CVD and diabetes

Experience

Education